Weighted Average Number of Shares Outstanding, Diluted of Horizon Therapeutics Public Ltd Co from 30 Jun 2010 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Horizon Therapeutics Public Ltd Co quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 30 Jun 2023.
  • Horizon Therapeutics Public Ltd Co Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2023 was 233,935,591, a 0.94% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 235,239,651, a 0.19% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 235,680,483, a 9.5% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 215,308,768, a 4.9% increase from 2019.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Horizon Therapeutics Public Ltd Co Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 233,935,591 -2,230,793 -0.94% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 233,788,366 -2,164,952 -0.92% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 235,239,651 -440,832 -0.19% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
Q3 2022 235,385,570 -813,219 -0.34% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 236,166,384 +974,524 +0.41% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 235,953,318 +12,032,550 +5.4% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 235,680,483 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 236,198,789 +12,454,886 +5.6% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 235,191,860 +42,486,325 +22% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 223,920,768 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q3 2020 223,743,903 +29,571,936 +15% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 192,705,535 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q3 2019 194,171,967 +21,686,210 +13% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020 2020 Q3
Q3 2018 172,485,757 +9,038,549 +5.5% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q3 2017 163,447,208 +2,408,381 +1.5% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 162,931,930 -988,651 -0.6% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q3 2016 161,038,827 -5,791,973 -3.5% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 163,920,581 +4,123,262 +2.6% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q3 2015 166,830,800 +81,143,533 +95% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 159,797,319 +86,412,518 +118% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q3 2014 85,687,267 +21,041,590 +33% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 73,384,801 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q3 2013 64,645,677 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2011 1,496,278 -10,867,300 -88% 01 Apr 2011 30 Jun 2011 10-Q 02 Sep 2011 2011 Q2
Q2 2010 12,363,578 01 Apr 2010 30 Jun 2010 10-Q 02 Sep 2011 2011 Q2

Horizon Therapeutics Public Ltd Co Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 235,239,651 -440,832 -0.19% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 235,680,483 +20,371,715 +9.5% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 215,308,768 +10,084,547 +4.9% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 205,224,221 +39,068,816 +24% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 166,155,405 +3,032,742 +1.9% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 163,122,663 +2,423,120 +1.5% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 160,699,543 +4,776,292 +3.1% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2018 2017 FY
2015 155,923,251 +72,172,122 +86% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 83,751,129 +20,093,205 +32% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 63,657,924 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.